Entrepreneur and early-stage investor focused on consumer and technology businesses, with operating experience in scaling marketplaces and founder-led teams. Known for hands-on growth work, Travis Weitz has founded and advised multiple startups, deploying seed and pre-seed capital and helping prepare companies for Series A exits. Background blends operator and angel investor roles; network-oriented approach to board advising, go-to-market, and capital formation.
Entrepreneur and early-stage investor focused on consumer and technology businesses, with operating experience in scaling marketplaces and founder-led teams. Known for hands-on growth work, Travis Weitz has founded and advised multiple startups, deploying seed and pre-seed capital and helping prepare companies for Series A exits. Background blends operator and angel investor roles; network-oriented approach to board advising, go-to-market, and capital formation.
Early-stage, founder-focused investor targeting consumer and technology businesses—especially marketplaces and network effects—where hands-on growth and go-to-market execution unlock scale. Prefers seed and pre-seed allocations with concentrated conviction bets and reserved follow-on capital for Series A. Underwrites teams by founder strength, unit economics, and clear customer LTV/CAC paths, using active mentorship, board-level operational support, and network-driven introductions to accelerate product-market fit. Time horizon is growth-oriented multi-year scale to exit; risk managed through stage discipline, rapid traction milestones, and operational involvement to derisk commercialization.
Early-stage, founder-focused investor targeting consumer and technology businesses—especially marketplaces and network effects—where hands-on growth and go-to-market execution unlock scale. Prefers seed and pre-seed allocations with concentrated conviction bets and reserved follow-on capital for Series A. Underwrites teams by founder strength, unit economics, and clear customer LTV/CAC paths, using active mentorship, board-level operational support, and network-driven introductions to accelerate product-market fit. Time horizon is growth-oriented multi-year scale to exit; risk managed through stage discipline, rapid traction milestones, and operational involvement to derisk commercialization.
| Trades 712 | Longs Won 479/712 67% | Profit Factor 4.59 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $127,309.56 |
| Average Win $55,261.11 | Best Trade (Aug 27) $1.24M | Sharpe Ratio -10.72 |
| Average Loss -$24,763.69 | Worst Trade (Sep 01) -$523,090.81 | Z-Score 7.84 (100%) |
| Commissions $0 | Avg. Trade Length 10m 3w 2d | Expectancy $29,073.22 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 4,525 | 4,072 | 3,620 | 3,167 | 2,715 | 2,262 | 1,810 | 1,357 | 905 | 452 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 6,782 | $1.69M | $2.1M | - | $406,949.43 | 24.11% | -7.354% |
ABBV AbbVie Inc. | 1,622 | $291,778.64 | $407,024.68 | - | $115,246.04 | 39.5% | -2.513% |
ABNB Airbnb, Inc. | 6,268 | $824,637.37 | $949,727.36 | - | $125,089.99 | 15.17% | -0.368% |
ABT Abbott Laboratories | 4,840 | $498,686.39 | $511,588 | - | $12,901.61 | 2.59% | +0.085% |
AKBA Akebia Therapeutics Inc. | 14,000 | $38,220 | $18,480 | - | -$19,740 | -51.65% | -2.222% |
ALB Albemarle Corporation | 4,256 | $358,195.78 | $500,675.84 | - | $142,480.06 | 39.78% | -0.102% |
AMAT Applied Materials, Inc. | 2,403 | $396,624.31 | $1.22M | - | $823,306.72 | 207.58% | +1.176% |
AMZN Amazon.com Inc | 8,276 | $1.82M | $2.25M | - | $431,342.58 | 23.75% | +15.321% |
ANET Arista Networks, Inc. | 6,175 | $716,723.93 | $1.11M | - | $396,937.38 | 55.38% | +5.456% |
APTV Aptiv PLC | 12,475 | $831,084.5 | $704,463.25 | - | -$126,621.25 | -15.24% | -2.789% |
ASUR Asure Software Inc. | 38,550 | $361,606.8 | $309,556.5 | - | -$52,050.3 | -14.39% | -4.062% |
AVGO Broadcom Inc. | 1,778 | $444,749.61 | $692,139.84 | - | $247,390.23 | 55.62% | +0.371% |
AXP American Express Company | 2,401 | $713,236.71 | $807,336.25 | - | $94,099.54 | 13.19% | -0.376% |
BMY Bristol-Myers Squibb Company | 4,931 | $278,899.26 | $322,043.61 | - | $43,144.35 | 15.47% | +0.694% |
BRK-B Berkshire Hathaway Inc. | 758 | $343,586.54 | $387,747.32 | - | $44,160.78 | 12.85% | +0.365% |
BSCR Invesco BulletShares 2027 Corporate Bond ETF | 31,940 | $622,755.49 | $626,183.7 | - | $3,428.21 | 0.55% | 0.0 |
BSCS Invesco BulletShares 2028 Corporate Bond ETF | 31,960 | $644,991.05 | $649,427.2 | - | $4,436.15 | 0.69% | -0.049% |
BSCT Invesco BulletShares 2029 Corporate Bond ETF | 65,332 | $1.2M | $1.21M | - | $8,056.02 | 0.67% | -0.054% |
BSCU Invesco BulletShares 2030 Corporate Bond ETF | 13,570 | $223,026 | $223,972.85 | - | $946.85 | 0.42% | -0.121% |
C Citigroup Inc. | 6,137 | $434,544.65 | $812,845.65 | - | $378,301 | 87.06% | +0.098% |